Original research
by
McDonald, Scott A. et al
Release Date
2023
Geography
UK
Language of Resource
English
Full Text Available
No
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
This study aimed to assess the impact of direct-acting antiviral (DAA) treatment success on quality of life (QoL) for people who inject drugs (PWID).
Findings/Key points
Successful direct-acting antiviral therapy for hepatitis C infection may not lead to a durable improvement in quality of life among people who inject drugs, although there may be a transient improvement around the time of sustained virologic response.
Design/methods
Cross sectional study (n=4009) and longitudinal study (n=83)
Keywords
About PWUD
Injecting drugs
Wrap-around services
Outcomes
